• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
MIKA Pharma GmbH - Product Pipeline Review - 2012 Product Image

MIKA Pharma GmbH - Product Pipeline Review - 2012

  • ID: 2167259
  • June 2012
  • 29 pages
  • Global Markets Direct

MIKA Pharma GmbH – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “MIKA Pharma GmbH - Product Pipeline Review - 2012” provides data on the MIKA Pharma GmbH’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, MIKA Pharma GmbH’s corporate website, SEC filings, investor presentations and featured press releases, both from MIKA Pharma GmbH and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- MIKA Pharma GmbH - Brief MIKA Pharma GmbH overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of MIKA Pharma GmbH human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination READ MORE >



List of Tables
List of Figures
MIKA Pharma GmbH Snapshot
MIKA Pharma GmbH Overview
Key Information
Key Facts
MIKA Pharma GmbH – Research and Development Overview
Key Therapeutic Areas
MIKA Pharma GmbH – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
MIKA Pharma GmbH – Pipeline Products Glance
MIKA Pharma GmbH – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
MIKA Pharma GmbH Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
MIKA Pharma GmbH – Drug Profiles
MK03
Product Description
Mechanism of Action
R&D Progress
MK22
Product Description
Mechanism of Action
R&D Progress
MK49
Product Description
Mechanism of Action
R&D Progress
MK50
Product Description
Mechanism of Action
R&D Progress
MK51
Product Description
Mechanism of Action
R&D Progress
MK52
Product Description
Mechanism of Action
R&D Progress
MIKA Pharma GmbH – Pipeline Analysis
MIKA Pharma GmbH – Pipeline Products by Therapeutic Class
MIKA Pharma GmbH – Pipeline Products By Target
MIKA Pharma GmbH – Pipeline Products by Route of Administration
MIKA Pharma GmbH – Pipeline Products By Mechanism of Action
MIKA Pharma GmbH – Locations And Subsidiaries
Head Office
Financial Deals Landscape
MIKA Pharma GmbH, Deals Summary
MIKA Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details
Partnerships
MIKA Pharma Enters Into Co-Development Agreement With GALENpharma
Acquisition
High Tech Beteiligungen Sells Mika Pharma To Giuliani
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
MIKA Pharma GmbH, Key Information
MIKA Pharma GmbH, Key Facts
MIKA Pharma GmbH – Pipeline by Indication, 2012
MIKA Pharma GmbH – Pipeline by Stage of Development, 2012
MIKA Pharma GmbH – Monotherapy Products in Pipeline, 2012
MIKA Pharma GmbH – Phase III, 2012
MIKA Pharma GmbH – Phase II, 2012
MIKA Pharma GmbH – Phase I, 2012
MIKA Pharma GmbH – Pipeline By Therapeutic Class, 2012
MIKA Pharma GmbH - Pipeline By Target, 2012
MIKA Pharma GmbH – Pipeline By Route of Administration, 2012
MIKA Pharma GmbH – Pipeline Products By Mechanism of Action, 2012
MIKA Pharma GmbH, Deals Summary
MIKA Pharma Enters Into Co-Development Agreement With GALENpharma
High Tech Beteiligungen Sells Mika Pharma To Giuliani

List of Figures
MIKA Pharma GmbH – Pipeline by Indication, 2012
MIKA Pharma GmbH – Pipeline by Stage of Development, 2012
MIKA Pharma GmbH – Monotherapy Products in Pipeline, 2012
MIKA Pharma GmbH – Pipeline By Therapeutic Class, 2012
MIKA Pharma GmbH - Pipeline By Target, 2012
MIKA Pharma GmbH – Pipeline By Route of Administration, 2012
MIKA Pharma GmbH - Pipeline Products By Mechanism of Action, 2012

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos